These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 35961374)

  • 21. Pharmacokinetics of hydroxychloroquine in Japanese systemic lupus erythematosus patients with renal impairment.
    Shimizu M; Furudate S; Nagai Y; Shimada K; Ohshima M; Setoguchi K; Hashiguchi M; Yokogawa N
    Mod Rheumatol; 2023 Aug; 33(5):953-960. PubMed ID: 36112484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of the stereoisomers of hydroxychloroquine and its major metabolites in plasma and urine following a single oral administration of racemic hydroxychloroquine.
    Iredale J; Fieger H; Wainer IW
    Semin Arthritis Rheum; 1993 Oct; 23(2 Suppl 1):74-81. PubMed ID: 8278822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QTc interval prolongation in patients with systemic lupus erythematosus treated with hydroxychloroquine.
    Nishiyama T; Kondo Y; Tsuboi H; Noma H; Tabuchi D; Sugita T; Okamoto S; Terasaki T; Shimizu M; Honda F; Ohyama A; Kurata I; Yagishita M; Abe S; Takahashi H; Osada A; Hagiwara S; Matsumoto I; Sumida T
    Mod Rheumatol; 2021 Nov; 31(6):1107-1112. PubMed ID: 33496215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety, Tolerability, and Pharmacokinetics of Nebulized Hydroxychloroquine: A Pilot Study in Healthy Volunteers.
    Hawari F; Dodin Y; Tayyem R; Najjar S; Kakish H; Fara MA; Zou'bi AA; Idkaidek N
    J Aerosol Med Pulm Drug Deliv; 2023 Apr; 36(2):76-81. PubMed ID: 36637803
    [No Abstract]   [Full Text] [Related]  

  • 25. QTc prolongation among hydroxychloroquine sulphate-treated COVID-19 patients: An observational study.
    Fteiha B; Karameh H; Kurd R; Ziff-Werman B; Feldman I; Bnaya A; Einav S; Orlev A; Ben-Chetrit E
    Int J Clin Pract; 2021 Mar; 75(3):e13767. PubMed ID: 33063447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simple dose-escalation regimen for hydroxychloroquine-induced hypersensitivity reaction in patients with systemic lupus erythematosus enabled treatment resumption.
    Takamasu E; Yokogawa N; Shimada K; Sugii S
    Lupus; 2019 Oct; 28(12):1473-1476. PubMed ID: 31575325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Capillary Electrophoresis-Based Method for the Measurement of Hydroxychloroquine and Its Active Metabolite Desethyl Hydroxychloroquine in Whole Blood in Patients with Rheumatoid Arthritis.
    Sotgia S; Zinellu A; Mundula N; Mangoni AA; Carru C; Erre GL
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35745021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chloroquine and hydroxychloroquine for COVID-19: Perspectives on their failure in repurposing.
    Shah RR
    J Clin Pharm Ther; 2021 Feb; 46(1):17-27. PubMed ID: 32981089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes and adverse events in patients hospitalised with COVID-19, treated with off-label hydroxychloroquine and azithromycin.
    Kelly M; O'Connor R; Townsend L; Coghlan M; Relihan E; Moriarty M; Carr B; Melanophy G; Doyle C; Bannan C; O'Riordan R; Merry C; Clarke S; Bergin C
    Br J Clin Pharmacol; 2021 Mar; 87(3):1150-1154. PubMed ID: 32687645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ).
    Naggie S; Milstone A; Castro M; Collins SP; Lakshmi S; Anderson DJ; Cahuayme-Zuniga L; Turner KB; Cohen LW; Currier J; Fraulo E; Friedland A; Garg J; George A; Mulder H; Olson RE; O'Brien EC; Rothman RL; Shenkman E; Shostak J; Woods CW; Anstrom KJ; Hernandez AF;
    Int J Infect Dis; 2023 Apr; 129():40-48. PubMed ID: 36682681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive factors for cardiac conduction abnormalities with hydroxychloroquine-containing combinations for COVID-19.
    Padilla S; Telenti G; Guillén L; García JA; García-Abellán J; Ding C; Mora A; García-Pachón E; Gutiérrez F; Masiá M;
    Int J Antimicrob Agents; 2020 Oct; 56(4):106142. PubMed ID: 32853675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular Safety of Hydroxychloroquine-Azithromycin in 424 COVID-19 Patients.
    Million M; Lagier JC; Hourdain J; Franceschi F; Deharo JC; Parola P; Brouqui P
    Medicina (Kaunas); 2023 Apr; 59(5):. PubMed ID: 37241095
    [No Abstract]   [Full Text] [Related]  

  • 33. Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID-19.
    Özdemir İH; Özlek B; Özen MB; Gündüz R; Çetin N; Bilge AR
    Int J Clin Pract; 2021 Feb; 75(2):e13896. PubMed ID: 33280207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
    McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
    Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study.
    Chen Z; Liu A; Cheng Y; Wang X; Xu X; Huang J; Ma Y; Gao M; Huang C
    BMC Infect Dis; 2021 Aug; 21(1):805. PubMed ID: 34384388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the risk of QTc prolongation associated with hydroxychloroquine use with antidepressants in lupus patients with fibromyalgia.
    Renaldi J; Koumpouras F; Dong X
    Lupus; 2021 Oct; 30(11):1844-1848. PubMed ID: 34353174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Day-90 survival in critically-ill patients with COVID-19 and hydroxychloroquine: a propensity analysis.
    Cour M; Amaz C; Bohé J; Rimmelé T; Ovize M; Argaud L
    Ann Transl Med; 2021 Apr; 9(7):524. PubMed ID: 33987222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
    de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
    Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus.
    Vázquez-Otero I; Medina-Cintrón N; Arroyo-Ávila M; González-Sepúlveda L; Vilá LM
    Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32434863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.